/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

style
pb-0

Ginkgo Bioworks Holdings Inc

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0
$9.04 0.0489(4.89%) DNA at 04 Dec 2025 04:29 PM Biotechnology
Lowest Today 8.65
Highest Today 9.03
Today’s Open 8.68
Prev. Close 8.59
52 Week High 17.58
52 Week Low 5.00
Day’s Range: Low 8.65 High 9.03
52-Week Range: Low 5.00 High 17.58
1 day return -
1 Week return -3.07
1 month return -22.26
3 month return -23.03
6 month return +18.83
1 year return -13.55
3 year return +402.23
5 year return -
10 year return -

Institutional Holdings

Viking Global Investors LP 6.04

Baillie Gifford & Co Limited. 5.53

BlackRock Inc 5.15

Scottish Mortgage Ord 4.04

Vanguard Group Inc 4.02

Erste Asset Management GmbH 3.38

Anchorage Advisors, LLC 2.95

L&G Artificial Intelligence ETF 2.56

Legal & General Group PLC 2.52

Millennium Management LLC 2.29

Vanguard Total Stock Mkt Idx Inv 2.17

Bank of America Corp 2.04

Goldman Sachs Group Inc 1.93

Forbes J M & Co 1.82

iShares Russell 2000 ETF 1.59

Geode Capital Management, LLC 1.58

Prescott Group Capital Management LLC 1.31

State Street Corp 1.25

SB INVESTMENT ADVISERS (UK) LTD 1.03

Morgan Stanley - Brokerage Accounts 0.86

Opaleye Management Inc 0.84

Baillie Gifford US Equity Growth 0.79

Vanguard US Growth Investor 0.79

Vanguard Institutional Extnd Mkt Idx Tr 0.75

Fidelity Small Cap Index 0.66

Jump Financial LLC 0.63

Robo Global® Artificial Intelligence ETF 0.58

Charles Schwab Investment Management Inc 0.56

Ensign Peak Advisors Inc 0.56

iShares Russell 2000 Value ETF 0.55

Fidelity Extended Market Index 0.38

iShares Biotechnology ETF 0.37

Baillie Gifford American B Inc 0.34

Schwab US Small-Cap ETF™ 0.33

Vanguard Russell 2000 ETF 0.31

State St Russell Sm Cap® Indx SL Cl I 0.23

Invesco RAFI US 1500 Small-Mid ETF 0.23

Schwab Small Cap Index 0.16

NT R2000 Index Fund - NL 0.16

iShares Genomics Immnlgy & Hlthcr ETF 0.16

Market Status

Strong Buy: 1

Buy: 0

Hold: 1

Sell: 3

Strong Sell: 1

Fundamentals

Market Cap 520.47 M

PB Ratio 0.9363

PE Ratio 0.0

Enterprise Value 485.11 M

Total Assets 1377.45 M

Volume 987775

Company Financials

Annual Revenue FY24:227043000 227.0M, FY23:314985000 315.0M, FY22:477706000 477.7M, FY21:313837000 313.8M, FY20:76657000 76.7M

Annual Profit FY24:188494000 188.5M, FY23:237373000 237.4M, FY22:273490000 273.5M, FY21:184147000 184.1M, FY20:61046000 61.0M

Annual Net worth FY24:-547029000 -547.0M, FY23:-856643000 -856.6M, FY22:-2106372000 -2106.4M, FY21:-1836642000 -1836.6M, FY20:-126723000 -126.7M

Quarterly Revenue Q3/2025:38837000 38.8M, Q2/2025:49604000 49.6M, Q1/2025:48318000 48.3M, Q3/2024:89046000 89.0M, Q2/2024:56206000 56.2M

Quarterly Profit Q3/2025:26035000 26.0M, Q2/2025:34782000 34.8M, Q1/2025:36271000 36.3M, Q3/2024:79059000 79.1M, Q2/2024:25155000 25.2M

Quarterly Net worth Q3/2025:-80755000 -80.8M, Q2/2025:-60300000 -60.3M, Q1/2025:-90957000 -91.0M, Q3/2024:-56403000 -56.4M, Q2/2024:-217181000 -217.2M

Fund house & investment objective

Company Information Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell programming in the United States. It operates through Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics and antibody developability Datapoints services, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the research, development, and commercialization of engineered organisms and derived products. It also provides biomonitoring and bioinformatics support services through Canopy, which generates genomic data from strategically positioned nodes through biomonitoring programs; and Horizon, a digital surveillance, analytics, and insights platform that detects and monitors biothreats. The company serves the pharmaceutical and biotechnology, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Organisation Biotechnology

Employees 834

Industry Biotechnology

CEO Dr. Jason Kelly Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow